MAPT and Alzheimer disease: On the imaging front, small-molecule probes have been developed to detect by positron emission tomography (PET) the defining β sheet amyloid aggregates in Alzheimer’s disease (AD) that are composed of β-amyloid (Aβ) peptide and tau protein.